1/2

FIEO Registered Export Ready

Nitroglycerin ControlledRelease Tablets 2.6 mg

Name: Nitroglycerin ControlledRelease Tablets 2.6 mg
Brand: indiglobal exports
SKU: 8520203
Availability: InStoreOnly

Sold by indiglobal exports · Service Provider , Professional Services, Exporter, Wholesaler · Panchkula, Haryana, India

Price

Price on request

In stock

Minimum order: 1 unit

Export Snapshot

MOQ

1 unit

Lead time

On request

Packaging

Standard export packaging

Shelf life / longevity

As per product specification

HSN Code

On request

Origin

India

Port of dispatch

On request

Export markets served

Global markets

Values shown are for indiglobal exports.

FIEO Registered

Suitable for

Importers · Distributors · Wholesalers

Panchkula Dispatch on request FIEO member

indiglobal exports

Service Provider , Professional Services, Exporter, Wholesaler · Panchkula, Haryana, India

We are a distinguished merchant trading and export company, specializing in the international supply of premium-quality products across various sectors. Our portfolio includes pharmaceuticals, marketed under a neutral code, as well as millets, mango pulp, compounded animal and livestock feed, and orthopaedic appliances. We take great pride in our meticulous product selection and procurement processes, consistently adhering to the highest standards of quality assurance to ensure the delivery of superior goods to our clients.

Registered address: Chandigarh, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Medical Equipment & Supplies.

View profile All products

Established

2024

Employees

1–10

GST

06EOGPS3248L1ZF

IEC code

Not shared

Export markets

Global markets

GlobalLinker Member Since

Apr 2024

Turnover

$50,000 - $250,000

Incorporation Type

On request

Certifications & Awards

IEC Certificate GST Certificate UDYAM Registration Certificate Certificate course in International trade-from FIEO FASSAI License Drug License

Product details

What are the specifications of this product?

Overview

Nitroglycerin Controlled Release Tablets 2.6 mg is a pharmaceutical product indicated for cardiac treatment. This formulation is manufactured with export-quality standards to ensure therapeutic efficacy, consistent dosage, and compliance with international healthcare regulations. Features: Used in the management of cardiac conditions Precise dosage form and active pharmaceutical ingredients Suitable for international pharmaceutical markets Manufactured in GMP-compliant facilities Reliable therapeutic performance Attributes: Category: Cardiac Formulation: Tablet Packaging: Export-grade blister or strip packs Shelf Life: As per regulatory standards Manufacturer: IndiGlobal Exports

Product Description

Product Overview

Nitroglycerin Controlled Release Tablets 2.6 mg is developed for the effective management of cardiac conditions, offering reliable performance backed by stringent pharmaceutical standards. Each batch is carefully produced and tested to ensure consistency, safety, and compliance with global export norms.

Therapeutic Use & Application

This formulation supports the clinical treatment and ongoing care of patients with cardiac indications. Commonly prescribed in hospital and retail pharmacy settings, it ensures measurable therapeutic benefit.

Formulation & Packaging

Crafted in state-of-the-art facilities, this tablet formulation ensures accuracy in dosing and ease of administration. It is typically available in secure blister or strip packs suitable for bulk export or institutional supply.

Quality & Compliance

The product is manufactured in facilities adhering to WHO-GMP standards and complies with pharmacopoeial quality benchmarks (IP/USP). Ideal for regulated and semi-regulated markets seeking quality-assured medications.

Description provided by indiglobal exports.

Specifications

Category	Cardiac Pharmaceutical
Formulation	Tablet
Active Pharmaceutical Ingredient (API)	Nitroglycerin 2.6 mg
Dosage Form	Controlled Release
Packaging Type	Blister or strip packs
Compliance Standards	WHO-GMP, IP/USP Pharmacopoeia
Intended Use	Therapeutic management of cardiac diseases
Shelf Life Duration	In accordance with regulatory requirements
Manufacturer	IndiGlobal Exports
Export Capability	Yes, suitable for regulated and semi-regulated international markets

Use cases

Category	Pharmaceuticals > Cardiovascular Drugs > Nitroglycerin Formulations > Controlled Release Tablets
Primary application	Wholesale, distribution, and international sourcing
Brand	indiglobal exports
Product type	Product

Logistics & handling

Lead time	On request
Packaging	As per buyer requirement
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 unit
Lead time	On request
Payment terms	As per negotiated commercial agreement.

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing Nitroglycerin ControlledRelease Tablets 2.6 mg. Answers compiled from verified sellers' commercial terms and platform data.

Q: What makes Nitroglycerin Controlled Release Tablets 2.6 mg suitable for export markets?

A: The tablets are produced under WHO-GMP certified facilities, comply with international pharmacopoeial standards (IP/USP), and are packaged in export-grade blister or strip packs, ensuring quality, safety, and stability required for global distribution.

Q: How does the controlled release formulation benefit patients using the Nitroglycerin Tablets 2.6 mg?

A: The controlled release mechanism provides a steady delivery of nitroglycerin over time, reducing fluctuations in blood levels, minimizing side effects, and improving therapeutic consistency, which enhances patient compliance and treatment outcomes.

Q: Can these tablets be used in both hospital and retail pharmacy settings?

A: Yes, the Nitroglycerin Controlled Release Tablets 2.6 mg are designed for clinical effectiveness and patient safety, making them suitable for prescription dispensing across hospitals and retail pharmacies.

Q: What quality standards does this product adhere to?

A: This product is manufactured in WHO-GMP compliant facilities and adheres to pharmacopoeial standards such as IP (Indian Pharmacopoeia) and USP (United States Pharmacopeia), ensuring high quality and efficacy.

Q: What type of packaging is used to maintain the stability of Nitroglycerin Controlled Release Tablets 2.6 mg?

A: The tablets are packaged in export-grade blister or strip packs that ensure protection from moisture, light, and mechanical damage during storage and transit.

Question not answered? Ask sellers directly — typical response within 4 hours.